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Abstract
Introduction: Single nucleotide polymorphism in the 3’ untranslated region of
the vesicle-associated membrane protein gene (VAMP-8) has been associated
with increased risk of early-onset myocardial infarction (MI). In this study the
risk of early onset MI conferred by VAMP-8 gene polymorphism was investigated
in a group of 171 male subjects.
Material and methods: Male patients with a history of MI who underwent
coronary angiography were enrolled and divided into early (incident < 55 years
of age) and late (incident ≥ 55 years of age) MI onset groups. Apart from the
RFLP-PCR based analysis of the VAMP-8 variant, history of hypertension, lipid
abnormalities, smoking and body mass index were recorded. In statistical
analyses odds ratios and relative risk were used as a measure of genotype-MI
association while logistic regression was implemented for evaluation of MI risk
factor strength.
Results: VAMP-8 A allele frequency proved to be significantly higher in the early-
onset MI group and conferred higher relative risk of early MI in the investigated
cohort, when calculated for the individual A allele (p = 0.029). In logistic
regression analyses no association between risk genotypes and traditional risk
factors was observed. 
Conclusions: In this study VAMP-8 A variant was identified as a risk allele for
early MI in male subjects.
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Introduction
Ischaemic heart disease (IHD) and its most grave consequence, namely
myocardial infarction (MI), remain among the most common public health
threats worldwide. High and medium income countries are strongly
affected, with the yearly rate of MI throughout Europe ranging from 90 to
312 per one hundred thousand individuals yearly and a high number of
myocardial infarction episodes with ST elevation (STEMI). In Poland
cardiovascular disease (CVD) remains a primary public health issue as well,
being the leading cause of death (45.6% in 2008). Among males below 59
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years of age CVD-associated mortality was three-
fold higher, with gender-related differences
becoming insignificant in older individuals [1].
Extensive, multicentre research has identified an
array of “classical” MI risk factors with age, smo  -
king, hypercholesterolaemia, hypertension, type 2
diabetes and positive IHD family history being the
most common [2]. It must be noted that genetic
factors should also be considered, as indicated by
family and gene variant association studies
performed on large groups and high numbers of
genetic markers [3-5]. Of these, high throughput
single nucleotide polymorphism (SNP) studies
resulting in the identification of risk-associated
alleles proved to be of the highest value [4, 6], with
results validated by risk-allele targeted association
studies [7, 8]. 
For this study a genetic variant of a vesicle-
associated membrane protein (VAMP), previously
unstudied in the Polish population, was selected.
Vesicle-associated membrane protein proteins play
a crucial role in the regulatory mechanisms of 
pla  telet secretory function [9]. It has been de  -
monstrated that cellubrevin (VAMP-3) and endo  -
brevin (VAMP-8) form soluble N-ethylmaleimide-
sensitive factor attachment protein receptor
(SNARE) complexes in human platelets and mediate
granule secretion [10, 11]. VAMP-8 gene poly  -
morphism in the 3’ untranslated region (accession
number rs 1010) has been identified as one of the
risk factors for early-onset MI in a large case-control
study analysing 11 647 human SNPs [6].
Associations between VAMP-8 gene poly  morphisms
and in vitro platelet functions were studied, but did
not give conclusive data on the polymorphism-
related mechanism of platelet dysfunction [12, 13].
The aim of this research was to analyse an
association between risk of early onset of MI (< 55
years of age) among male subjects and VAMP-8
gene polymorphism (rs 1010). This is the first study
on Polish subjects and in the North-European area. 
Material and methods
Subjects
The study protocol was approved by the local
Ethical Committee with all patients voluntarily
consenting to participate in the research. 
For the study group 171 male patients (mean age
of 55.7 ±9.8 years) were enrolled. All cases had
a history of MI and underwent interventional
procedures (coronary angiography) at the
Department of Cardiology, Pomeranian Medical
University, Szczecin. The group was divided into
early-onset MI (infarction below the age of 55 years,
n = 103) and late onset MI subgroups (infarction at
the age ≥ 55 years, n = 68). Resting ECG was
performed in all cases; full medical and treatment
history including smoking status was obtained and
body mass index was calculated. Biochemical
analyses in this group included determination of
serum total cholesterol and triglyceride
concentrations prior to the angiography. For genetic
analyses whole blood samples were collected on
EDTA anticoagulant. All subjects were treated
according to the IHD treatment guidelines with ACE
inhibitors, statin, β-blockers, and aspirin. The study
protocol was approved by the local Bioethics
Committee.
Genotyping
The QIAamp DNA Blood Mini Kit (QIAgen, Hilden,
Germany) was used to extract genomic DNA from
blood samples. The extraction was performed by
following the manufacturer’s protocol. DNA was re-
suspended in 200 μl of AE buffer (QIAgen, Hilden,
Germany) and stored at 4°C for further analyses.
Identification of VAMP-8 A/G gene polymorphism
was performed by a PCR method, previously
described by Shiffman, using the following primers:
sense: 5´- GGG GGC TCC AAC TTT CTT CTC C and
antisense 5´- CTT TGC CAC TGG TGC CTT CTC TTA
[6]. RFLP of the PCR product with the restriction
enzyme Mae II was performed; for the A allele the
final product of 494 base pairs (b.p.) remained
undigested, while the G variant gave digested
products of 328 b.p. and 166 b.p. Products were
electrophoresed in agarose gel stained with
ethidium bromide and analysis results were
recorded digitally. 
Statistical analysis
Allele and genotype frequencies among cases
and controls were compared with values predicted
by the Hardy-Weinberg equilibrium. Odds ratios
(OR) were calculated as a measure of association
between genotype and MI. For each OR, we cal  -
culated the 2-tailed probability value and 95% CI.
Odds ratios and p values were calculated separately
for A and G alleles. 
A value of p < 0.05 was considered as indicative
of a statistically significant effect. Logistic regression
models were designed to evaluate the importance
of risk factors in MI.
Results
Clinical and laboratory characteristics of early
and late-onset MI subgroups are presented in 
Table I. Power of the analysis was supported by the
strong statistical difference observed for the age
criterion, applied after division into the subgroups.
Additionally, lipid concentrations were higher in the
early-onset MI group, while a notably higher
number of hypertensive individuals was observed
in the late onset MI group. No significant differences442 Arch Med Sci 3, June / 2011
concerning smoking or body mass index were
observed between the subgroups. 
Allele and genotype distributions for both
subgroups are presented in Table II. Distribution of
individual AA, AG and GG genotypes did not differ
significantly between the subgroups, while A allele
frequency was significantly higher among subjects
with early-onset MI (below the age of 55 years)
when compared to late-onset MI (above 55 years).
Relative risk (RR) of early-onset MI was de  -
monstrated to be higher in individuals carrying 
the A allele. RR was calculated for both the
individual A allele (difference statistically significant, 
p = 0.029) and A allele containing genotypes
(statistical differences not significant); in our study
A was proven to be an early-MI risk associated
allele. 
Additionally, diagnosis of hypertension, smoking
status, BMI, total cholesterol and triglyceride levels
were correlated by logistic regression with
frequency of the investigated alleles and genotypes,
but no association between risk genotypes and
traditional risk factors was observed.
Discussion
In this study the hypothesis that VAMP-8 rs1010
single nucleotide polymorphism is associated with
increased risk of early-onset myocardial infarction
was tested. This SNP was selected after a review
of existing research data, in which it has been
defined as one of the risk alleles for coronary heart
disease, early-onset MI and ischaemic stroke in
Caucasian populations [3, 7]. The decision to limit
our study to male cases only was based on the
genetic risk analysis performed in the study by
Shifmann to maximize the possibility to obtain
a valid result [6]. Moreover, cardiovascular disease
incidence among young men is higher than among
young women and therefore genetic risk factor
identification is of higher importance in this group.
Influence of the VAMP-8 rs1010 variants was
proven to be additive, and was included in
a coronary heart disease genetic risk score model
for the Atherosclerosis Risk in Communities study
[14]. As most of the studies so far have been
performed in the United States, our study aimed
to confirm the risk association described above in
the Polish population, which could be representative
of North-European populations. Extensive genetic
research has been published in the field of genetic
factors associated with early-onset coronary artery
disease [15, 16], but precise identification of single
nucleotide risk variants remains infrequent.
VAMP-8 rs1010 SNP was associated with early-
onset MI in our study, with the A variant identified
as the risk allele. It must be noted that such
a finding is discordant with the data published
before, where the G allele was indicated to be
associated with enhanced risk in the large-scale
SNP genotyping study performed by Shifmann in
order to identify MI early-onset genetic risk factors
[6]. That study was performed on a group of
American Caucasians with MI diagnosed at age 
< 55 among male subjects and < 60 for females;
the odds ratio (OR) related to the disease was 1.26
for the G risk allele for the entire group, while the
estimated risk for this variant was even higher for
males (OR 1.97). However, this analysis was
unadjusted for age and diabetes. Additionally, in
the aforementioned Atherosclerosis Risk in
Communities  study a high genetic risk score,
defined as the presence of five single nucleotide
polymorphisms including VAMP-8 rs1010, was
associated with increased risk of incident coronary
heart disease (CHD) after adjusting for traditional
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Variable MI < 55 MI ≥ 55 Value of p
Age of MI 47.3 ±5.2 63.4 ±6.2 0.001
Hypertension [%] 44 60 0.033
Smokers [%] 61 54 0.380
Body mass index  27.2 ±3.4 27.0 ±3.6 0.667
[kg/m2]
Total cholesterol  230 ±40 218 ±39 0.056
[mg/dl]
Triglycerides [mg/dl] 201 ±157 158 ±74 0.035
Table I. Baseline clinical and laboratory characteristics
of study patients
Genetic variant MI < 55, n (%) MI ≥ 55, n (%) ORA (95% CI)V alue of p ORG (95% CI)V alue of p
AA + AG 93 (90.3) 57 (83.8) 1.63 (0.63-4.23) 0.309 – –
AA 49 (47.6) 21 (30.9) 2.24 (0.78-6.41) 0.128 1 –
AG 44 (42.7) 36 (52.9) 1.37 (0.50-3.75) 0.531 0.66 (0.32-1.35) 0.247
GG 10 (9.7) 11 (16.2) 1 – 0.45 (0.16-1.28) 0.128
AG + GG 54 (52.4) 47 (69.1) – – 0.60 (0.31-1.18) 0.136
A 142 (68.9) 78 (57.4) 1.65 (1.03-2.65) 0.029 – –
G 64 (31.1) 58 (42.6) – – 0.61 (0.38-0.97) 0.029
Table II. VAMP-8 polymorphism associated risk of myocardial infarction in Polish males
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risk factors. In this study an association between
the G risk allele and myocardial infarction was also
confirmed [3, 14]. These association analyses were
performed for white populations, but no variable of
early-onset MI was analysed. 
On the other hand, van der Net et al., in an
association study performed on patients with
familial hypercholesterolaemia, did not confirm the
findings of increased risk related to the VAMP-8
rs1010 variants [8]. This study was performed on
relatively young (mean age of 48.8 years) Caucasian
Europeans and might indicate a possible association
between coronary heart disease and MI risk with
this SNP .
It must also be noted that the sample analysed
in our study is a Caucasian population from the
north-western region of Poland, which due to the
post-war migration is highly likely to be genetically
diverse. The VAMP-8 allelic frequency is therefore
highly likely to be similar in the whole of Poland.
A strong influence of classical, environmental CVD
and MI risk factors in the Polish population has
been previously confirmed [17] but this genetic, risk-
allele based study contributes to the knowledge
concerning the genetic epidemiology of CAD.
A limitation of the study is related to the fact
that the occurrence of classical risk factors in the
Polish population is high and thus they may play
a greater role in atherosclerosis pathogenesis than
genetic factors. However, further gene association
studies are necessary for younger populations, with
shorter time of exposure to MI-promoting environ  -
mental factors, such as smoking, diet or obesity,
where genetic risk factors would be of even greater
influence and importance. 
In conclusion, VAMP-8 rs1010 gene variants are
related to the risk of early-onset myocardial
infarction, with further gene association studies
necessary for confirmation of its exact influence on
coronary artery disease. 
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